降尿酸方治疗慢性肾脏病3-4期伴高尿酸血症的疗效观察
|
摘要
目的：在优质低蛋白低嘌呤饮食、碱化尿液、降压、调脂的基础上,观察降尿酸方治疗慢性肾脏病3～4期伴高尿酸血症的疗效,以及血尿酸(SUA)改变对肾功能的影响,探讨其治疗机制。
方法：2009年1月至2010年12月在江苏省中医院门诊或住院治疗的符合纳入条件的患者56例,治疗组、对照组各28例,在优质低蛋白低嘌呤饮食、碱化尿液、降压、调脂等治疗的基础上,治疗组予降尿酸方结合辨证加味治疗,对照组予中医辨证治疗,疗程8周。观察治疗前后血尿酸(SUA)及血尿素氮(Bun)、肌酐(Scr)的变化,以及24h尿蛋白定量(U-TP)、血浆白蛋白(Alb)、总胆固醇(TC)、甘油三脂(TG)、不良反应等。
结果：1、高尿酸血症(HUA)及肾功能的疗效,治疗组优于对照组(P<0.05)。2、治疗组治疗后SUA明显下降,对照组无明显变化,两组比较有统计学意义(P<0.05)。3、治疗组治疗后Bun、Scr下降,eGFR升高,对照组均无明显变化,其中Scr、eGFR两组比较有统计学意义(P<0.05)。4、治疗组治疗后U-TP亦有下降,对照组无明显变化,两组比较有统计学意义(P<0.05),两组患者Hb、A1b、TG、TG治疗前后均无明显变化。5、SUA水平变化与肾功能变化之间存在直线正相关。
结论：1、降尿酸方能降低慢性肾脏病3～4期伴高尿酸血症患者的SUA水平。2、降低SUA水平有助于延缓慢性肾脏病3～4期伴高尿酸血症患者肾功能的进展。
Objective:On the basis of quality low-protein, low purine diet, alkaline urine, pressure control and lipid regulation, to observe the curative effect of JIANG-NIAO-SUAN-FANG treating the chronic kidney disease 3-4 phase with hyperuricemia, as well as the influence of serum uric acid changing to renal function, to discuss the treatment mechanism.
Methods:Collect 56 qualified outpatients or hospitalized patients of Chinese medicinehospital in Jiangsu Province hospital from January 2009 to December 2010, and the number of patient in the treatment group or control group is 28. On the basis of low purine diet, alkaline urine, pressure control and lipid regulation, the period of the treatment group(n = 28) treated with JIANG-NIAO-SUAN-FANG and the control group(n=28) treated with routine Chinese medicinem is 8 weeks. The patients are observed on the change of serum uric acid(SUA), blood urea nitrogen(Bun), Creatinine(Scr) before and after treatment, meanwhile observed on the change of 24h urine protein with quantitative(U-TP), plasma albumin(Alb), total cholesterol(TC), triglycerides(TG) and adverse reaction.
Results:1. Judge from the effect of hyperuricemia and renal function, the curative effect of treatment group is better than control group(P<0.05).2. The SUA level of patients in treatment group falls down significantly, with no obvious change in the control group, two groups of comparison has a statistical significance(P<0.05).3. In the treatment group, the Bun, Scr level of patients is down but eGFR level is up after treatment with no obvious change in the control group, and two therapeutic indexes(Scr, eGFR) change, two groups of comparison has a statistical significance(P<0.05).4. The U-TP level of patients in treatment group is down too after treatment, with no obvious change in the control group, two groups of comparison has a statistical significance(P<0.05); Hb, Alb, TC and TG of patients in two groups do not change obviously before and after treatment, two groups of comparison has no statistical significance(P>0.05).5. There is a positive correlation between SUA and renal function.
Conclusions:1. JIANG-NIAO-SUAN-FANG can reduce the SUA level of patients who have the Chronic kidney disease(CKD) 3-4 phase with hyperuricemia.2. Reducing the SUA level is helpful for improving the renal funcion status of patients who have the Chronic kidney disease(CKD) 3-4 phase with hyperuricemia.
方法：2009年1月至2010年12月在江苏省中医院门诊或住院治疗的符合纳入条件的患者56例,治疗组、对照组各28例,在优质低蛋白低嘌呤饮食、碱化尿液、降压、调脂等治疗的基础上,治疗组予降尿酸方结合辨证加味治疗,对照组予中医辨证治疗,疗程8周。观察治疗前后血尿酸(SUA)及血尿素氮(Bun)、肌酐(Scr)的变化,以及24h尿蛋白定量(U-TP)、血浆白蛋白(Alb)、总胆固醇(TC)、甘油三脂(TG)、不良反应等。
结果：1、高尿酸血症(HUA)及肾功能的疗效,治疗组优于对照组(P<0.05)。2、治疗组治疗后SUA明显下降,对照组无明显变化,两组比较有统计学意义(P<0.05)。3、治疗组治疗后Bun、Scr下降,eGFR升高,对照组均无明显变化,其中Scr、eGFR两组比较有统计学意义(P<0.05)。4、治疗组治疗后U-TP亦有下降,对照组无明显变化,两组比较有统计学意义(P<0.05),两组患者Hb、A1b、TG、TG治疗前后均无明显变化。5、SUA水平变化与肾功能变化之间存在直线正相关。
结论：1、降尿酸方能降低慢性肾脏病3～4期伴高尿酸血症患者的SUA水平。2、降低SUA水平有助于延缓慢性肾脏病3～4期伴高尿酸血症患者肾功能的进展。
Objective:On the basis of quality low-protein, low purine diet, alkaline urine, pressure control and lipid regulation, to observe the curative effect of JIANG-NIAO-SUAN-FANG treating the chronic kidney disease 3-4 phase with hyperuricemia, as well as the influence of serum uric acid changing to renal function, to discuss the treatment mechanism.
Methods:Collect 56 qualified outpatients or hospitalized patients of Chinese medicinehospital in Jiangsu Province hospital from January 2009 to December 2010, and the number of patient in the treatment group or control group is 28. On the basis of low purine diet, alkaline urine, pressure control and lipid regulation, the period of the treatment group(n = 28) treated with JIANG-NIAO-SUAN-FANG and the control group(n=28) treated with routine Chinese medicinem is 8 weeks. The patients are observed on the change of serum uric acid(SUA), blood urea nitrogen(Bun), Creatinine(Scr) before and after treatment, meanwhile observed on the change of 24h urine protein with quantitative(U-TP), plasma albumin(Alb), total cholesterol(TC), triglycerides(TG) and adverse reaction.
Results:1. Judge from the effect of hyperuricemia and renal function, the curative effect of treatment group is better than control group(P<0.05).2. The SUA level of patients in treatment group falls down significantly, with no obvious change in the control group, two groups of comparison has a statistical significance(P<0.05).3. In the treatment group, the Bun, Scr level of patients is down but eGFR level is up after treatment with no obvious change in the control group, and two therapeutic indexes(Scr, eGFR) change, two groups of comparison has a statistical significance(P<0.05).4. The U-TP level of patients in treatment group is down too after treatment, with no obvious change in the control group, two groups of comparison has a statistical significance(P<0.05); Hb, Alb, TC and TG of patients in two groups do not change obviously before and after treatment, two groups of comparison has no statistical significance(P>0.05).5. There is a positive correlation between SUA and renal function.
Conclusions:1. JIANG-NIAO-SUAN-FANG can reduce the SUA level of patients who have the Chronic kidney disease(CKD) 3-4 phase with hyperuricemia.2. Reducing the SUA level is helpful for improving the renal funcion status of patients who have the Chronic kidney disease(CKD) 3-4 phase with hyperuricemia.
引文
[1]Chen S,Du H,Wang Y,et al.The epidemiology study of hyperuricemia and gout in a community population of Huangpu district in Shanghai[J].Chin Med J,1998,111 (3):228-230.
[2]Curhan GC,Mitch WE.Diet and kidney disease.//Brenner BM.The kidney.8th ed,Vol2.Philadelphia: Saunders,2008,1827-1847.
[3]Johnson RJ,Kang DH.Feig D,et al.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease.Hypertension,2003,41:1183-1190.
[4]李丽,李南,白树功,等.急性心肌梗塞与血尿酸浓度关系探讨[J].心肺血管病杂志,1999,18(4)：275-277.
[5]邵继红.高尿酸血症与痛风的分子流行病学研究进展[J].国外医学卫生学分册,2003,30(4)：238-242.
[6]滕森新,郑洁(译).高尿酸血症[J].日本医学介绍,2001,22(7)：307-309.
[7]Lohsoonthorn V,Dhanamun B,Williams MA.Prevalence of hyperuricemia and its relationship with metabotic syndrome in Thai adults receiving annual health exams[J].ArchMed Res,2006,37(7):883-889.
[8]Chien KL,Hsu HC,Sung FC,et al.Hyperuricemia as a risk factor on cardiovascular events in Taiwan:The Chin-Shan Community Cardiovascular Cohort Study[J].Atherosclerosis,2005,183(1):147-155.
[9]方圻,游凯,林其燧,等.中国正常人血尿酸调查及其与血脂的关系[J].中华内科杂志,1983,22(7)：434.
[10]徐晓菲,姜宝法,张源潮,等.山东沿海地区人群血尿酸水平极其在痛风筛检中的意义[J].中国公共卫生,1999,15(3)：205.
[11]杜蕙,陈顺乐,王员,等.上海市黄浦区小区高尿酸血症与痛风流行病学调查[J].中华风湿病学杂志,1998,2(2)：75.
[12]余俊文,陆锦波,张小娟,等.1320名老年人血尿酸与血脂、血糖和血压的分析[J].中华流行病学杂志,2005,26(6)：455-457.
[13]田小草,逢增昌,包国春,等.青岛市居民高尿酸血症患者及影响因素分析[J].中国公共卫生,2008,24(3)：360-362.
[14]陈秀玲,邹玉蓉,李贵森,等.四川地区高尿酸血症及其影响因素分析[J].四川医学,2008,29(9)：1267-1269.
[15]贾育红,崔刘福,杨文浩,等.唐山矿区人群高尿酸血症和痛风的患病率调查[J].中国煤炭工业医学杂志,2009,12(6)：8-9.
[16]文育锋,许静,叶冬青,等.芜湖市中老年人群高尿酸血症影响因素分析[J].中国公共卫生,2010,3(6)：39-40.
[17]Ames BN,Cathcart R,Schwiers E,et al.Uric-acid provides an antioxidant defense in humans aga inst oxidant and radical-caused aging and cancer a hypothesis[J].Proc Natl Acad Sci USA,1981,78 (11):6858-6862.
[18]蒋光荣,郑恒,邵少慰.高尿酸血症的研究进展[J].医学综述,2008,14(11)：1673-1675.
[19]陈颖,李长贵,苗志敏.原发性高尿酸血症发病机制的研究进展[J].国际遗传学杂志,2006,29(1)：59-65.
[20]孙瑞霞.人肾脏尿酸盐转运的分子机制研究进展[J].国外医学泌尿系统分册,2005,25(3)：281-286.
[21]刘爱华,黄慈波.原发性高尿酸血症与痛风代谢相关基因研究进展[J].中国临床保健杂志,2004,7(5)：395-398.
[22]孙玉萍,姚华.低排泄型高尿酸血症相关候选基因研究进展[J].国际遗传学杂志,2006,29(5)：397-400.
[23]Nyhan WL.Dopamine function in Lesclr Nyhan disease. Environ Health Perspect,2000;108(Suppl 3):409-413.
[24]Chou JY,Matern D,Mansfield BC,Chen YT.Type ivglycogen storage diseases:Disorders of the glucose 6-phosphatase complex.Curr Mol Med,2002;2(2):121-124.
[25]Matern D,Seydewitz HH,Bali D,et al.Glycogen storage disease type iv:Diagnosis and phenotype /genotype correlation.Eur J Pediatr,2002;161(Suppl 1):10-19
[26]陈香美,吴镝.尿酸性肾病[J].中华内科杂志,2005,44(3)：231-233.
[27]王庆文.高尿酸血症及其肾损害的治疗[J].肾脏病与透析肾移植杂志,2009,18(3)：47-48.
[28]Kang DH,Nakagawa T,Feng L,et al.A role for uric acid in the progression of renal disease.J Am Soc Nephro,l 2002,13:2888-2897.
[29]Mazzali M,Hughes J,Kim YG,et al.Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.Hypertension,2001,38:1101-1106.
[30]Sanchez-Lozada LG,Tapia E,Santamaria J,et al.Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats[J].Kidney Int,2005,67(1):237-247.
[31]邱强,陈香美,谢院生,等.影响IgA肾病高尿酸血症的因素[J].中国中西医结合肾病杂志,2005,6(6)：329-331.
[32]Sanchez-Lozada LG,Tapia E,Lopez-Molina R,et al.Effects of acute and chronic L-arginine treatmentin experimental hyperuricemia[J].Am J Physiol Rena Physiol,2007,292(4):F1238-F1244.
[33]Marilda M,John K,Lin H,et al.Hyperuricaemia induce a primary renal arteriolopathy in rats by a blood pressure-indepentent mechanism[J].AJP-Renal Physiology,2002,282(6):991-997.
[34]刘佳,李玲.高尿酸血症的发病机制与药物治疗研究进展[J].国际约学研究杂志,2010,37(1)：24-28.
[35]Terlouw SA,Masereeuw R,Russel FGM.Modulatory effects of hormones,drugs,and toxic events on renal organic anion transporter.Bioehem Phamaeol,2003;65(9):1393-1405.
[36]Freedman DS,Williamson DF,Gentr EW,et al.Relation of serum acid to mortality and ischemic heart disease.The NHANNESI Eoidemiologic Follow-up study[J].Am J Epidemiol,1995,141(7):637-644.
[37]Nieto FJ,Lribarren C,GrossMD,et al.Uric acid and serumanti oxidant capacity,a reaction to athe rosclerosis?[J].Atherosclerosis,2000,148(1):131-139.
[38]吕建国,梁爽霖.冠心病与血尿酸的关系[J].中国心血管杂志,2001,3(4)：288-289.
[39]Anker SD,Doehner W,Rauchhaus M,et al.Uric acid and survival inchronic heart failure:validation and application in metabolic,functional,and hemodynamic staging[J].Circulation,2003,107(15):1991-1997.
[40]Olexa P,Olexova M,Gonsorcik J,et al.Uric acid--a marker for system-ic inflammatory response in patients with congestive heart failure?[J].Wien Klin Wochenschr,2002,114(5-6):211-215.
[41]Leyva F,Anker SD,Godsland IF,et al.Uric acid in chronic heart failure:a marker of chronic inflammation[J].Eur Heart J,1998,19(12):1814-1822.
[42]Leyva F,Anker S,Swan JW,et al.Serum uric acid as an index of im-paired oxidative metabolism in chronic heart failure[J].Eur Heart J,1997,18(5):858-865.
[43]Cappola TP,Kass DA,Nelson GS,et al.Allopurinol improves myocar-dial efficiency in patients with idiopathic dilated cardiomyopathy[J].Circulation,2001,104(20):2407-2411.
[44]叶健烽,陈展中,卫展扬.血尿酸对急性心肌梗死预后的影响[J].新医学,2002,33(9)：536-537.
[45]朱文华,方力争,李楠,等.代谢综合征各组分对高尿酸血症的影响[J].中华内科杂志,2006,45(3)：228.
[46]Jossa F,Farinaro E,Panico S,et al.Serum uric acidand hypertension:the olivetti heart study[J].J Hum Hypertens,1994,8(9):677.
[47]Verdecchia P,Schillaci G,Reboldi G,et al.Relation between serumuric acid and risk of cardiovascular disease in essential hypertension.The PIUMA study[J].Hpertension,2000,36(6):1072.
[48]马学毅.2型糖尿病伴高尿酸血症的病因和治疗进展[J].中华老年多器官病杂志,2005,4(1)：20.
[49]Lehto S,Niskanen L,Ronnemaa T,et al.Serum uric-acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes meltitus[J].Stroke,1998,29(3):635.
[50]Bo S,Cavallo-Perin P,C-entile L,et al.Hypouricemia and hyperuricemia in type 2 diabetes:two different phenotypes[J].Eur J Clin Invest,2001,31:318.
[51]Tsunoda S,Kamide K,Minami J,et al.Decreases inserum uric acid by aelioration of insulin resistance in overweight hypertensive patients:effect of a low-energy diet and all insulin-sensitizing agent[J].Am J Hypertens,2002,15(8):697.
[52]李东晓,迟家敏.高尿酸血症与代谢综合征[M].国外医学内分泌学分册,2004,26(6)：386.
[53]宋娓,李长贵.原发性高尿酸血症与代谢综合征关系的研究进展[J].山东医药,2006,46(7)：77-78.
[54]孙丽英,牛秀波,李建博,等.2004年河北省沧州市1215例男性血尿酸、血脂水平分析及痛风发病率的相关调查[J].中国医学检验杂志,2005,6(2)：135-157.
[55]Dincer HE,Dincer AP,Levinson DJ.Asymptomatic hyperuricemia to treat or not to treat[J].Cleve Clin J M ed,2002,69(8):594-597.
[56]Roch-Ramel F,Guisan B,Diezi J.Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles[J].J Pharm Exp Ther,1997,280(2):839-845.
[57]Bomalaski JS,Clark MA.Serum uricacid-lowering therapies:where are we heading in management of hyperuricemia and the potential role of uricase.Curr Rheumatol Rep,2004,6(3):240-247.
[58]Yim BT,Sims-McCallum RP,ChongPH.Rasburicase for the treatment and prevention of hyperuri-cemia[J].Ann Pharmacother,2003,37(8):1047-1054.
[59]林穗芳.健脾固肾利湿法治疗高尿酸血症23例疗效观察[J].新中医,2004,36(10)：22-23.
[60]干玉明,张云云.五苓散加味治疗高尿酸血症临床观察[J].北京中医杂志,2003,22(1)：19-20.
[61]赵恒侠.高尿酸血症与痰湿瘀浊综合征辨析[J].河南中医学院学报,2003,18(5)：41-42.
[62]张永生.姜良铎教授治疗痛风经验[J].北京中医药大学学报,2002,8(2)：61-62.
[63]王进军.张荒生治疗痛风经验[J].实用中医内科杂志,2006,20(1)：23-24.
[64]解国华,周乃玉.中医药治疗痛风性关节炎的研究[J].北京中医,2002,21(2)：122-125.
[65]蔡浙毅,费秀丽,吴锋,等.中药酸方防治高尿酸血.症疗效观察[J].辽宁中医杂志2007,34(11):1579-1580.
[66]李承恩,谈文峰.“秦虎汤”治疗无症状性高尿酸血症48例[J].江苏中医药,2004,25(4)：22-23.
[67]周苇.平胃散合五苓散治疗高尿酸血症36例[J].浙江中医药大学学报,2007,31(2)：182-183.
[68]李俊.健脾四妙汤治疗高尿酸血症临床疗效分析[J].中医药导报,2010,16(5)：51-52.
[69]张良茂.补肾利湿法治疗高尿酸血症临床观察[J].上海中医药杂志,2002,3：23-24.
[70]张爱玲.化浊汤治疗高尿酸血症44例临床观察[J].江苏中医药,2004,25(12)：31-32.
[71]刘孟渊.分期辨治痛风性关节炎例疗效观察[J].新中医,2000,32(8)：16-18.
[72]刘志勤,吕蕾.中医分期治疗痛风体会[J].浙江中西医结合杂志,2003,13(3)：178-180.
[73]夏建龙.周福贻教授治疗痛风性关节炎的经验[J].江苏中医,2000,21(12)：22-24.
[74]蒋唯强.试论痛风从脏腑辨证论治[J].浙江中医杂志,2000,35(4)：168.
[75]黄秀珍,陶雨药.辨证治疗痛风性关节炎56例临床观察[J].湖南中医杂志,2003,19(2)：23-24.
[76]毛碧峰.辨证分型治疗痛风性关节炎56例[J].实用中医内科杂志,2008,22(4)：49-50.
[77]由显.痛风膏治疗急性痛风性关节炎80例体会[J].辽宁中医杂志,2006,33(6)：698-670.
[78]钱小强.青敷膏治疗急性痛风性关节炎43例[J].实用中医药杂志,2005,21(1)：30-31.
[79]印山水,宋琴华.加味丁桂散及海浮散外敷治疗痛风性关节186例[J].中医外治杂志,12002,11(5)：17-18.
[80]严试.复方蚂蚁膏外敷治疗痛风性关节炎45例[J].中医外治杂志,200l,10(1)：11-13.
[81]陈廷生.中药外洗法治疗急性痛风性关节炎128例[J].中医外治杂志,2008,17(5)：39-41.
[82]曹瑞竹,张三印,代勇,等.秦皮总香豆素降低小鼠急性高尿酸血症血尿酸水平及机理研究[J].辽宁中医杂志,2010,37(2)：362-364.
[83]林伟青,谢建祥,王海东.白艾提取液对高尿酸血症大鼠的实验研究[J].中华风湿病学杂志,2005,9(8)：509-511.
[84]薛莎,朱琼洁,马威.伸秦组方对高尿酸血症小鼠的影响[J].中国药物经济学,2010,2：87-88.
[85]李亚芹,刘文敏,马焕云.当归补血汤对高尿酸血症肾损害的保护作用研究[J].时珍国医国药,2009,20(12)：3065-3066.
[86]National Kidney Foundation-K/DOQI.Clinical Practice Guidelines for chronic kidney disease,eva-luation,classification and stratification[J].Am J Kidney Dis,2002,39:1-266.
[87]陈灏珠.实用内科学[M].第11版,人民卫生出版社,2001：2365.
[88]郑筱萸主编.《中药新药临床研究指导原则》(试行).北京：中国医药科技出版社,2002：164.
[89]中医药管理局.《中医病证诊断疗效标准》.北京：人民卫生出版社,1996：05.
[90]张秋华,张晓枫,张秋菊.苍术的化学成分与药理研究进展[J].时珍国药研究,1997,8(6)：505-506.
[91]Sakurai T,Yamada H,Saito K,et al.Enzyme inhibitory activities of acetylene and sesquiterpene compounds in atractylodes rhizome.Biol Pharm Bull,1993,16(2):142.
[92]赵爱梅.苍术的药理作用研究[J].光明中医,2009,24(1)：181-182.
[93]卓新凤.薏苡仁的药理研究与临床应用体会[J].中国中医药现代远程教育,2009,7(8)：211-21.
[94]王咏梅,楚瑞琦,谢瑞娟,等.玉米须提取液对糖尿病大鼠早期肾脏病变的影响[J].山东中医杂志,2008,27(6)：411-413.
[95]洪秋菊,任远.玉米须的化学成分与药理研究[J].甘肃中医学院学报,2010,27(4)：74-77.
[96]刘军,刘静波,王作昭,等.玉米须黄酮类化合物构效及合成基因调控研究进展[J].食品科学,2010,3l(13)：316-320.
[97]康白,张义军,李华洲.丝瓜络的药理作用初探[J].潍坊医学院学报,1993,15(3)：180-183.
[98]许莉莉,康白,韩慧蓉,等.丝瓜络对慢性充血性心衰模型大鼠利尿作用及机制的研究[J].山东中医杂志,2010,28(11)：778-779.
[99]张存莉,刘虎岐,傅建熙.药用植物土茯苓研究进展[J].陕西林业科技,1999,(3)：60-63.
[100]王德军,寿旗扬,周卫民,等.土茯苓对糖尿病肾病大鼠糖代谢及肾功能的影响[J].中华中医药学刊,2009,27(12)：2662-2664.
[101]费洪荣,毛幼桦,朱玮,等.粉萆薜降尿酸作用研究[J].医药导报,2007,26(11)：1270-1272.
[102]李雪征,金光洙.萆解的研究进展[J].中国野生植物资源,2002,21(5)：8-10.
[103]李莹莹,李均.虎杖对肾缺血再灌注损伤大鼠血清超氧化物歧化酶和丙二醛的影响[J].辽宁中医药大学学报,2009,11(12)：166-167.
[104]伍晓春,陆豫.虎杖的药理作用及临床应用研究进展[J].中医药信息,2005,22(2)：22-25.
[105]蒙爱东.药用植物广金钱草的研究进展[J].广西科学院学报,2008,24(2)：148-151.
[106]凌婷,杨勇健.怀牛膝的药理作用及其未来应用展望[J].临床医药实践,2009,18(7)：1879-1880.
[107]张杰,杨旭东,詹必勋,等.怀牛膝对糖尿病大鼠肾脏保护作用及其机制研究[J].中医研究,2010,23(4)：16-18.
[108]孙艳秋,刘珂,王守愚,等.槲寄生的研究进展[J].中草药,2000,3l(6)：471-474.
[109]李均,李莹莹,曹轶璇,等.虎杖对肾缺血.-灌注损伤大鼠肾组织内皮素和核转录因子的影响[J].中药材,2010,33(9)9-1472.
[110]从茅苍术得到新的多炔化合物,可作血小板聚集抑制剂治疗心肌梗塞脑血栓.国外医药分册,1993,8(4)：191.
[111]李小玲,李菁,朱伟杰,等.丝瓜络对高脂血症小鼠LDL-R基因表达的影响[J].中国病理生理杂志,2009,25(6)：116-1159.
[2]Curhan GC,Mitch WE.Diet and kidney disease.//Brenner BM.The kidney.8th ed,Vol2.Philadelphia: Saunders,2008,1827-1847.
[3]Johnson RJ,Kang DH.Feig D,et al.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease.Hypertension,2003,41:1183-1190.
[4]李丽,李南,白树功,等.急性心肌梗塞与血尿酸浓度关系探讨[J].心肺血管病杂志,1999,18(4)：275-277.
[5]邵继红.高尿酸血症与痛风的分子流行病学研究进展[J].国外医学卫生学分册,2003,30(4)：238-242.
[6]滕森新,郑洁(译).高尿酸血症[J].日本医学介绍,2001,22(7)：307-309.
[7]Lohsoonthorn V,Dhanamun B,Williams MA.Prevalence of hyperuricemia and its relationship with metabotic syndrome in Thai adults receiving annual health exams[J].ArchMed Res,2006,37(7):883-889.
[8]Chien KL,Hsu HC,Sung FC,et al.Hyperuricemia as a risk factor on cardiovascular events in Taiwan:The Chin-Shan Community Cardiovascular Cohort Study[J].Atherosclerosis,2005,183(1):147-155.
[9]方圻,游凯,林其燧,等.中国正常人血尿酸调查及其与血脂的关系[J].中华内科杂志,1983,22(7)：434.
[10]徐晓菲,姜宝法,张源潮,等.山东沿海地区人群血尿酸水平极其在痛风筛检中的意义[J].中国公共卫生,1999,15(3)：205.
[11]杜蕙,陈顺乐,王员,等.上海市黄浦区小区高尿酸血症与痛风流行病学调查[J].中华风湿病学杂志,1998,2(2)：75.
[12]余俊文,陆锦波,张小娟,等.1320名老年人血尿酸与血脂、血糖和血压的分析[J].中华流行病学杂志,2005,26(6)：455-457.
[13]田小草,逢增昌,包国春,等.青岛市居民高尿酸血症患者及影响因素分析[J].中国公共卫生,2008,24(3)：360-362.
[14]陈秀玲,邹玉蓉,李贵森,等.四川地区高尿酸血症及其影响因素分析[J].四川医学,2008,29(9)：1267-1269.
[15]贾育红,崔刘福,杨文浩,等.唐山矿区人群高尿酸血症和痛风的患病率调查[J].中国煤炭工业医学杂志,2009,12(6)：8-9.
[16]文育锋,许静,叶冬青,等.芜湖市中老年人群高尿酸血症影响因素分析[J].中国公共卫生,2010,3(6)：39-40.
[17]Ames BN,Cathcart R,Schwiers E,et al.Uric-acid provides an antioxidant defense in humans aga inst oxidant and radical-caused aging and cancer a hypothesis[J].Proc Natl Acad Sci USA,1981,78 (11):6858-6862.
[18]蒋光荣,郑恒,邵少慰.高尿酸血症的研究进展[J].医学综述,2008,14(11)：1673-1675.
[19]陈颖,李长贵,苗志敏.原发性高尿酸血症发病机制的研究进展[J].国际遗传学杂志,2006,29(1)：59-65.
[20]孙瑞霞.人肾脏尿酸盐转运的分子机制研究进展[J].国外医学泌尿系统分册,2005,25(3)：281-286.
[21]刘爱华,黄慈波.原发性高尿酸血症与痛风代谢相关基因研究进展[J].中国临床保健杂志,2004,7(5)：395-398.
[22]孙玉萍,姚华.低排泄型高尿酸血症相关候选基因研究进展[J].国际遗传学杂志,2006,29(5)：397-400.
[23]Nyhan WL.Dopamine function in Lesclr Nyhan disease. Environ Health Perspect,2000;108(Suppl 3):409-413.
[24]Chou JY,Matern D,Mansfield BC,Chen YT.Type ivglycogen storage diseases:Disorders of the glucose 6-phosphatase complex.Curr Mol Med,2002;2(2):121-124.
[25]Matern D,Seydewitz HH,Bali D,et al.Glycogen storage disease type iv:Diagnosis and phenotype /genotype correlation.Eur J Pediatr,2002;161(Suppl 1):10-19
[26]陈香美,吴镝.尿酸性肾病[J].中华内科杂志,2005,44(3)：231-233.
[27]王庆文.高尿酸血症及其肾损害的治疗[J].肾脏病与透析肾移植杂志,2009,18(3)：47-48.
[28]Kang DH,Nakagawa T,Feng L,et al.A role for uric acid in the progression of renal disease.J Am Soc Nephro,l 2002,13:2888-2897.
[29]Mazzali M,Hughes J,Kim YG,et al.Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.Hypertension,2001,38:1101-1106.
[30]Sanchez-Lozada LG,Tapia E,Santamaria J,et al.Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats[J].Kidney Int,2005,67(1):237-247.
[31]邱强,陈香美,谢院生,等.影响IgA肾病高尿酸血症的因素[J].中国中西医结合肾病杂志,2005,6(6)：329-331.
[32]Sanchez-Lozada LG,Tapia E,Lopez-Molina R,et al.Effects of acute and chronic L-arginine treatmentin experimental hyperuricemia[J].Am J Physiol Rena Physiol,2007,292(4):F1238-F1244.
[33]Marilda M,John K,Lin H,et al.Hyperuricaemia induce a primary renal arteriolopathy in rats by a blood pressure-indepentent mechanism[J].AJP-Renal Physiology,2002,282(6):991-997.
[34]刘佳,李玲.高尿酸血症的发病机制与药物治疗研究进展[J].国际约学研究杂志,2010,37(1)：24-28.
[35]Terlouw SA,Masereeuw R,Russel FGM.Modulatory effects of hormones,drugs,and toxic events on renal organic anion transporter.Bioehem Phamaeol,2003;65(9):1393-1405.
[36]Freedman DS,Williamson DF,Gentr EW,et al.Relation of serum acid to mortality and ischemic heart disease.The NHANNESI Eoidemiologic Follow-up study[J].Am J Epidemiol,1995,141(7):637-644.
[37]Nieto FJ,Lribarren C,GrossMD,et al.Uric acid and serumanti oxidant capacity,a reaction to athe rosclerosis?[J].Atherosclerosis,2000,148(1):131-139.
[38]吕建国,梁爽霖.冠心病与血尿酸的关系[J].中国心血管杂志,2001,3(4)：288-289.
[39]Anker SD,Doehner W,Rauchhaus M,et al.Uric acid and survival inchronic heart failure:validation and application in metabolic,functional,and hemodynamic staging[J].Circulation,2003,107(15):1991-1997.
[40]Olexa P,Olexova M,Gonsorcik J,et al.Uric acid--a marker for system-ic inflammatory response in patients with congestive heart failure?[J].Wien Klin Wochenschr,2002,114(5-6):211-215.
[41]Leyva F,Anker SD,Godsland IF,et al.Uric acid in chronic heart failure:a marker of chronic inflammation[J].Eur Heart J,1998,19(12):1814-1822.
[42]Leyva F,Anker S,Swan JW,et al.Serum uric acid as an index of im-paired oxidative metabolism in chronic heart failure[J].Eur Heart J,1997,18(5):858-865.
[43]Cappola TP,Kass DA,Nelson GS,et al.Allopurinol improves myocar-dial efficiency in patients with idiopathic dilated cardiomyopathy[J].Circulation,2001,104(20):2407-2411.
[44]叶健烽,陈展中,卫展扬.血尿酸对急性心肌梗死预后的影响[J].新医学,2002,33(9)：536-537.
[45]朱文华,方力争,李楠,等.代谢综合征各组分对高尿酸血症的影响[J].中华内科杂志,2006,45(3)：228.
[46]Jossa F,Farinaro E,Panico S,et al.Serum uric acidand hypertension:the olivetti heart study[J].J Hum Hypertens,1994,8(9):677.
[47]Verdecchia P,Schillaci G,Reboldi G,et al.Relation between serumuric acid and risk of cardiovascular disease in essential hypertension.The PIUMA study[J].Hpertension,2000,36(6):1072.
[48]马学毅.2型糖尿病伴高尿酸血症的病因和治疗进展[J].中华老年多器官病杂志,2005,4(1)：20.
[49]Lehto S,Niskanen L,Ronnemaa T,et al.Serum uric-acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes meltitus[J].Stroke,1998,29(3):635.
[50]Bo S,Cavallo-Perin P,C-entile L,et al.Hypouricemia and hyperuricemia in type 2 diabetes:two different phenotypes[J].Eur J Clin Invest,2001,31:318.
[51]Tsunoda S,Kamide K,Minami J,et al.Decreases inserum uric acid by aelioration of insulin resistance in overweight hypertensive patients:effect of a low-energy diet and all insulin-sensitizing agent[J].Am J Hypertens,2002,15(8):697.
[52]李东晓,迟家敏.高尿酸血症与代谢综合征[M].国外医学内分泌学分册,2004,26(6)：386.
[53]宋娓,李长贵.原发性高尿酸血症与代谢综合征关系的研究进展[J].山东医药,2006,46(7)：77-78.
[54]孙丽英,牛秀波,李建博,等.2004年河北省沧州市1215例男性血尿酸、血脂水平分析及痛风发病率的相关调查[J].中国医学检验杂志,2005,6(2)：135-157.
[55]Dincer HE,Dincer AP,Levinson DJ.Asymptomatic hyperuricemia to treat or not to treat[J].Cleve Clin J M ed,2002,69(8):594-597.
[56]Roch-Ramel F,Guisan B,Diezi J.Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles[J].J Pharm Exp Ther,1997,280(2):839-845.
[57]Bomalaski JS,Clark MA.Serum uricacid-lowering therapies:where are we heading in management of hyperuricemia and the potential role of uricase.Curr Rheumatol Rep,2004,6(3):240-247.
[58]Yim BT,Sims-McCallum RP,ChongPH.Rasburicase for the treatment and prevention of hyperuri-cemia[J].Ann Pharmacother,2003,37(8):1047-1054.
[59]林穗芳.健脾固肾利湿法治疗高尿酸血症23例疗效观察[J].新中医,2004,36(10)：22-23.
[60]干玉明,张云云.五苓散加味治疗高尿酸血症临床观察[J].北京中医杂志,2003,22(1)：19-20.
[61]赵恒侠.高尿酸血症与痰湿瘀浊综合征辨析[J].河南中医学院学报,2003,18(5)：41-42.
[62]张永生.姜良铎教授治疗痛风经验[J].北京中医药大学学报,2002,8(2)：61-62.
[63]王进军.张荒生治疗痛风经验[J].实用中医内科杂志,2006,20(1)：23-24.
[64]解国华,周乃玉.中医药治疗痛风性关节炎的研究[J].北京中医,2002,21(2)：122-125.
[65]蔡浙毅,费秀丽,吴锋,等.中药酸方防治高尿酸血.症疗效观察[J].辽宁中医杂志2007,34(11):1579-1580.
[66]李承恩,谈文峰.“秦虎汤”治疗无症状性高尿酸血症48例[J].江苏中医药,2004,25(4)：22-23.
[67]周苇.平胃散合五苓散治疗高尿酸血症36例[J].浙江中医药大学学报,2007,31(2)：182-183.
[68]李俊.健脾四妙汤治疗高尿酸血症临床疗效分析[J].中医药导报,2010,16(5)：51-52.
[69]张良茂.补肾利湿法治疗高尿酸血症临床观察[J].上海中医药杂志,2002,3：23-24.
[70]张爱玲.化浊汤治疗高尿酸血症44例临床观察[J].江苏中医药,2004,25(12)：31-32.
[71]刘孟渊.分期辨治痛风性关节炎例疗效观察[J].新中医,2000,32(8)：16-18.
[72]刘志勤,吕蕾.中医分期治疗痛风体会[J].浙江中西医结合杂志,2003,13(3)：178-180.
[73]夏建龙.周福贻教授治疗痛风性关节炎的经验[J].江苏中医,2000,21(12)：22-24.
[74]蒋唯强.试论痛风从脏腑辨证论治[J].浙江中医杂志,2000,35(4)：168.
[75]黄秀珍,陶雨药.辨证治疗痛风性关节炎56例临床观察[J].湖南中医杂志,2003,19(2)：23-24.
[76]毛碧峰.辨证分型治疗痛风性关节炎56例[J].实用中医内科杂志,2008,22(4)：49-50.
[77]由显.痛风膏治疗急性痛风性关节炎80例体会[J].辽宁中医杂志,2006,33(6)：698-670.
[78]钱小强.青敷膏治疗急性痛风性关节炎43例[J].实用中医药杂志,2005,21(1)：30-31.
[79]印山水,宋琴华.加味丁桂散及海浮散外敷治疗痛风性关节186例[J].中医外治杂志,12002,11(5)：17-18.
[80]严试.复方蚂蚁膏外敷治疗痛风性关节炎45例[J].中医外治杂志,200l,10(1)：11-13.
[81]陈廷生.中药外洗法治疗急性痛风性关节炎128例[J].中医外治杂志,2008,17(5)：39-41.
[82]曹瑞竹,张三印,代勇,等.秦皮总香豆素降低小鼠急性高尿酸血症血尿酸水平及机理研究[J].辽宁中医杂志,2010,37(2)：362-364.
[83]林伟青,谢建祥,王海东.白艾提取液对高尿酸血症大鼠的实验研究[J].中华风湿病学杂志,2005,9(8)：509-511.
[84]薛莎,朱琼洁,马威.伸秦组方对高尿酸血症小鼠的影响[J].中国药物经济学,2010,2：87-88.
[85]李亚芹,刘文敏,马焕云.当归补血汤对高尿酸血症肾损害的保护作用研究[J].时珍国医国药,2009,20(12)：3065-3066.
[86]National Kidney Foundation-K/DOQI.Clinical Practice Guidelines for chronic kidney disease,eva-luation,classification and stratification[J].Am J Kidney Dis,2002,39:1-266.
[87]陈灏珠.实用内科学[M].第11版,人民卫生出版社,2001：2365.
[88]郑筱萸主编.《中药新药临床研究指导原则》(试行).北京：中国医药科技出版社,2002：164.
[89]中医药管理局.《中医病证诊断疗效标准》.北京：人民卫生出版社,1996：05.
[90]张秋华,张晓枫,张秋菊.苍术的化学成分与药理研究进展[J].时珍国药研究,1997,8(6)：505-506.
[91]Sakurai T,Yamada H,Saito K,et al.Enzyme inhibitory activities of acetylene and sesquiterpene compounds in atractylodes rhizome.Biol Pharm Bull,1993,16(2):142.
[92]赵爱梅.苍术的药理作用研究[J].光明中医,2009,24(1)：181-182.
[93]卓新凤.薏苡仁的药理研究与临床应用体会[J].中国中医药现代远程教育,2009,7(8)：211-21.
[94]王咏梅,楚瑞琦,谢瑞娟,等.玉米须提取液对糖尿病大鼠早期肾脏病变的影响[J].山东中医杂志,2008,27(6)：411-413.
[95]洪秋菊,任远.玉米须的化学成分与药理研究[J].甘肃中医学院学报,2010,27(4)：74-77.
[96]刘军,刘静波,王作昭,等.玉米须黄酮类化合物构效及合成基因调控研究进展[J].食品科学,2010,3l(13)：316-320.
[97]康白,张义军,李华洲.丝瓜络的药理作用初探[J].潍坊医学院学报,1993,15(3)：180-183.
[98]许莉莉,康白,韩慧蓉,等.丝瓜络对慢性充血性心衰模型大鼠利尿作用及机制的研究[J].山东中医杂志,2010,28(11)：778-779.
[99]张存莉,刘虎岐,傅建熙.药用植物土茯苓研究进展[J].陕西林业科技,1999,(3)：60-63.
[100]王德军,寿旗扬,周卫民,等.土茯苓对糖尿病肾病大鼠糖代谢及肾功能的影响[J].中华中医药学刊,2009,27(12)：2662-2664.
[101]费洪荣,毛幼桦,朱玮,等.粉萆薜降尿酸作用研究[J].医药导报,2007,26(11)：1270-1272.
[102]李雪征,金光洙.萆解的研究进展[J].中国野生植物资源,2002,21(5)：8-10.
[103]李莹莹,李均.虎杖对肾缺血再灌注损伤大鼠血清超氧化物歧化酶和丙二醛的影响[J].辽宁中医药大学学报,2009,11(12)：166-167.
[104]伍晓春,陆豫.虎杖的药理作用及临床应用研究进展[J].中医药信息,2005,22(2)：22-25.
[105]蒙爱东.药用植物广金钱草的研究进展[J].广西科学院学报,2008,24(2)：148-151.
[106]凌婷,杨勇健.怀牛膝的药理作用及其未来应用展望[J].临床医药实践,2009,18(7)：1879-1880.
[107]张杰,杨旭东,詹必勋,等.怀牛膝对糖尿病大鼠肾脏保护作用及其机制研究[J].中医研究,2010,23(4)：16-18.
[108]孙艳秋,刘珂,王守愚,等.槲寄生的研究进展[J].中草药,2000,3l(6)：471-474.
[109]李均,李莹莹,曹轶璇,等.虎杖对肾缺血.-灌注损伤大鼠肾组织内皮素和核转录因子的影响[J].中药材,2010,33(9)9-1472.
[110]从茅苍术得到新的多炔化合物,可作血小板聚集抑制剂治疗心肌梗塞脑血栓.国外医药分册,1993,8(4)：191.
[111]李小玲,李菁,朱伟杰,等.丝瓜络对高脂血症小鼠LDL-R基因表达的影响[J].中国病理生理杂志,2009,25(6)：116-1159.